ACTIVE_NOT_RECRUITING

Guaranteed Income and Financial Treatment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes? Participants will: Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors

Official Title

Guaranteed Income and Financial Treatment Trial

Quick Facts

Study Start:2023-04-01
Study Completion:2026-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06611982

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age = 18 or older
  2. 2. Newly diagnosed or recurrent advanced cancer (Stage 3 or 4)
  3. 3. Receiving chemotherapy or immunotherapy (with or without radiation) at one of the recruitment sites
  4. 4. Within 12 months of receiving systemic therapy and on surveillance at one of the recruitment sites
  5. 5. ECOG performance status of 1 - 2
  6. 6. A Pennsylvania Medicaid beneficiary
  7. 7. A Pennsylvania resident
  1. 1. Eligible for hospice (i.e. determined by provider to have a prognosis of 6 months or less) at time of randomization
  2. 2. Unable to communicate in English, Spanish, or Mandarin

Contacts and Locations

Principal Investigator

Meredith Doherty
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Pennsylvania Hospital
Philadelphia, New York, 19107
United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104
United States
Jefferson Health
Philadelphia, Pennsylvania, 19107
United States

Collaborators and Investigators

Sponsor: Meredith Doherty, PhD, LCSW

  • Meredith Doherty, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-01
Study Completion Date2026-07-30

Study Record Updates

Study Start Date2023-04-01
Study Completion Date2026-07-30

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Financial Hardship
  • Quality of Life